Landos Biopharma Inc reports results for the quarter ended in June - Earnings Summary

Landos Biopharma

29/07/2021 14:52

* Landos Biopharma Inc  LABP.OQ  reported quarterly adjusted
earnings of 12 cents​​ per share for the quarter ended in June.
The mean expectation of four analysts for the quarter was for a
loss of 14 cents per share.
* Revenue was $18.00 million​;  analysts expected zero. 
* Landos Biopharma Inc's reported EPS for the quarter was 12
cents​.
* The mean earnings estimate of analysts had risen by
about 62.9% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Landos Biopharma Inc shares had risen by 0.1% this quarter.
* The company reported quarterly net income of $4.1 million.
* Wall Street's median 12-month price target for Landos
Biopharma Inc is $32.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 29 at 01:52 p.m.  ​All
figures in US dollars unless otherwise stated